Skip to content

Use of EMG to Assess Clinical Hypertonia

Initial Assessment of the Use of Surface Electromyography as a Tool for Clinical Evaluation of Hypertonia in Children

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00472914
Enrollment
14
Registered
2007-05-14
Start date
2007-01-31
Completion date
2007-03-31
Last updated
2014-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy, Dystonia, Hypertonia, Rigidity, Spasticity

Keywords

Hypertonia, Childhood

Brief summary

A handheld surface electromyography device will be tested by clinicians on children with limb hypertonia, and inter-rater reliability will be assessed with and without the device.

Detailed description

Hypothesis: Qualitative surface EMG measurement during passive movement will increase the inter-rater reliability of clinicians for diagnosis of spasticity and dystonia in children with hypertonia. Specific Aims: 1. Develop a handheld surface EMG device with auditory output that can be used similarly to a stethoscope to listen non-invasively to the activity of muscles. 2. Provide clinicians at 5 different institutions with a device to test for 2 months in their own clinics. 3. Bring all 5 clinicians to Stanford University for a single-day exercise in which each clinician will examine 10 children with hypertonia. Each clinician will rate the children without using the device, and then again with the device. Intra-class correlations and kappa statistics will be used to assess whether the use of the device leads to improved inter-rater reliability.

Interventions

DEVICEportable surface electromyography

Sponsors

University of Southern California
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Age 6-18 * hypertonia in at least one limb due to spasticity

Exclusion criteria

* any condition that would increase the risk of participation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026